Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |